\Ablon Skin Institute and Research Center
Manhattan Beach, California 90266
3 studies enrolling now · 16 studies all time
What they study most
Acne, Acne Vulgaris, Actinic Keratosis (AK), Atopic Dermatitis, Atopic Dermatitis (AD), Central Abdominal Bulging, Chin Augmentation, Chin Retrusion, Glabellar Frown Lines, Hair Thinning, Lateral Canthal Lines, Moderate to Severe Glabellar Lines
Studies at this site
- Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo — Recruiting now
- A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows — Recruiting now
- Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR) — Recruiting now
- Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis — Completed
- Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
- Study Evaluating the Efficacy and Safety of Omnilux Clear on Mitigating Mild to Moderate Acne — Completed
- A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair. — Running, not enrolling
- A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA) — Completed
- Nutraceutical Supplement With Vegan Botanicals in Females With Self-Perceived Thinning Hair — Completed
- Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair — Completed
- Treatment of Moderate to Severe Lateral Canthal Lines — Completed
- Treatment of Moderate to Severe Glabellar Lines — Completed
- A Study to Evaluate the Safety and Efficacy of Restylane Defyne for Chin Augmentation and Correction of Chin Retrusion — Completed
- Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2) — Completed
- Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat — Completed
- Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects — Completed